Provide immunity for administration of naloxone, nalmefene, or other federally approved opioid overdose reversal medications
LB195 amends Nebraska’s Uniform Controlled Substances Act to create legal protections for people who obtain and administer opioid overdose reversal medications, including naloxone and nalmefene. The bill allows health professionals authorized to prescribe or dispense these medications to provide them to people at risk of overdose, as well as to family members, friends, school personnel, and other bystanders who may be in a position to help. It also protects emergency responders and peace officers who obtain and administer these medications in good faith.
The bill is designed to encourage rapid overdose response by reducing fear of administrative discipline, criminal prosecution, and civil liability for good-faith actions related to obtaining or administering opioid overdose reversal medication. It defines key terms such as health professional, emergency responder, law enforcement agency, law enforcement employee, peace officer, and opioid overdose reversal medication, and it repeals the prior section of law to replace it with the updated immunity framework.
LB195 changes state law by expanding immunity protections for individuals and professionals involved in opioid overdose reversal efforts. It affects the Uniform Controlled Substances Act and related liability provisions by shielding covered persons from administrative action, criminal prosecution, and most civil liability when acting in good faith, while preserving liability for willful, wanton, or grossly negligent conduct. The bill also broadens the statutory framework to include federally approved overdose reversal medications beyond naloxone, which may affect prescribing, dispensing, emergency response protocols, and school or community overdose intervention practices.
The bill appears to have been broadly supported and noncontroversial. It advanced and passed with unanimous or near-unanimous votes at each recorded stage, including final passage by a 47-0 vote with two present and not voting. The lack of recorded committee testimony in the provided materials also suggests limited public opposition or debate in the available record.
No major points of contention are reflected in the provided transcripts or voting history. The main policy choice in the bill is the scope of immunity: it protects good-faith conduct by health professionals, emergency responders, peace officers, family members, friends, and school personnel, but it does not shield willful, wanton, or grossly negligent conduct. Any potential concern would likely center on balancing overdose-response access and liability protection against accountability for improper administration, but no specific opposition is shown in the record provided.